scholarly journals Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study

2020 ◽  
Vol 137 ◽  
pp. 224-234
Author(s):  
Deborah Meyran ◽  
Arnaud Petit ◽  
Joelle Guilhot ◽  
Meinolf Suttorp ◽  
Petr Sedlacek ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Blastic Phase

P108 Central nervous system blastic phase in chronic myeloid leukaemia during imatinib treatment

Blood Reviews ◽  
2007 ◽  
Vol 21 ◽  
pp. S121
Author(s):  
A. Kiss ◽  
A. Ujfalusy ◽  
T. Csepany ◽  
Gy. Remenyi ◽  
P. Batar ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Imatinib Treatment ◽  
Blastic Phase

Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping—Experience in 60 patients

1988 ◽  
Vol 12 (6) ◽  
pp. 499-506 ◽  
Author(s):  
Tapan Saikia ◽  
Suresh Advani ◽  
Amar Dasgupta ◽  
Gopal Ramakrishnan ◽  
Chadrika Nair ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Blastic Phase ◽  
Blast Cells

Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia

2000 ◽  
Vol 109 (4) ◽  
pp. 722-728 ◽  
Author(s):  
Giuseppe Visani ◽  
Gianantonio Rosti ◽  
Giuseppe Bandini ◽  
Patrizia Tosi ◽  
Alessandro Isidori ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Chronic Phase ◽  
Blastic Phase

Haematological Disease Pattern at Specialized HOPD - A study in Bangabandhu Sheikh Mujib Medical University

2018 ◽  
Vol 2 (02) ◽  
pp. 39-41
Author(s):  
Md. Rafiquzzaman Khan ◽  
Arifur Rahman ◽  
Khaza Amirul Islam ◽  
AQM Ashraful Haque ◽  
Masuda Begum
Keyword(s):  
Iron Deficiency ◽  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Iron Deficiency Anaemia ◽  
Beta Thalassemia ◽  
Female Ratio ◽  
Deficiency Anaemia ◽  
Beta Thalassaemia ◽  
Hb E ◽  
Medical University

The aim of this retrospective observational study was to observe the pattern and frequency of haematological disorders among the patients attending in the specialized Haematology outpatient Department (HOPD) in Bangabandhu Sheikh Mujib Medical University. Consecutive 201 patients over the period of one year were enrolled. Their age ranged from 01 to 72 years with a mean age of 36.76 years. Most of the patients (34.3%) were in between the ages of 31 to 45 years followed by 16 to 30 years (27.9%). Male to female ratio was 0.65. Iron deficiency anaemia is the most common (24.9%) followed by chronic myeloid leukaemia (11.9%), Hb E beta thalassaemia (9.5%), idiopathic thrombocytopenic purpura (9.5%), beta thalassaemia trait (7.0%), Hb E trait (5.5 %), aplastic anaemia (5.0%), multiple myeloma (3.5%), acute lymphoblastic leukaemia (3.0%). Acute myeloid leukaemia, autoimmune haemolytic anaemia, chronic lymphocytic leukaemia, anaemia of chronic disease, non-Hodgkin lymphoma, polycythaemia, beta thalassemia major and alpha thalassemia was 2.5%, 2.5%, 2.0%, 1.5%, 1.5%, 1.5%, 1.0% and 1.0%, respectively. In the present study, we observed that iron deficiency anaemia the most common non-malignant disease and chronic myeloid leukaemia is the common haematological malignancy.

Chronic Myeloid Leukaemia

2017 ◽  
Vol 1 (01) ◽  
pp. 16-22
Author(s):  
Mohiuddin Ahmed Khan ◽  
Mafruh Akter ◽  
Muhammad Kamruzzaman
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia

TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia

2020 ◽  
Author(s):  
Simone Claudiani ◽  
Jane F. Apperley ◽  
Richard Szydlo ◽  
Afzal Khan ◽  
George Nesr ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Dose Reduction ◽  
Molecular Remission
Sign in / Sign up

Export Citation Format

Share Document